Achilles Therapeutics Gets 180-Day Extension After Nasdaq Market Transfer
Achilles Therapeutics has received approval to transfer its listing from the Nasdaq Global Market to...
Achilles Therapeutics has received approval to transfer its listing from the Nasdaq Global Market to...
LONDON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) today announced that on November 15, 2024, the...